Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 421

1.

Self-Concept Clarity and the Bodily Self: Malleability Across Modalities.

Krol SA, Thériault R, Olson JA, Raz A, Bartz JA.

Pers Soc Psychol Bull. 2019 Oct 11:146167219879126. doi: 10.1177/0146167219879126. [Epub ahead of print]

PMID:
31603025
2.

Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial.

Sparano JA, Gray RJ, Makower DF, Albain KS, Saphner TJ, Badve SS, Wagner LI, Kaklamani VG, Keane MM, Gomez HL, Reddy PS, Goggins TF, Mayer IA, Toppmeyer DL, Brufsky AM, Goetz MP, Berenberg JL, Mahalcioiu C, Desbiens C, Hayes DF, Dees EC, Geyer CE Jr, Olson JA Jr, Wood WC, Lively T, Paik S, Ellis MJ, Abrams J, Sledge GW Jr.

JAMA Oncol. 2019 Sep 30. doi: 10.1001/jamaoncol.2019.4794. [Epub ahead of print]

PMID:
31566680
3.

The Pupillary Response to the Unknown: Novelty Versus Familiarity.

Beukema S, Jennings BJ, Olson JA, Kingdom FAA.

Iperception. 2019 Sep 7;10(5):2041669519874817. doi: 10.1177/2041669519874817. eCollection 2019 Sep-Oct.

4.

Retrospective comparison of two enoxaparin dosing and monitoring protocols at a pediatric hospital.

Wolsey A, Wilcox RA, Olson JA, Boehme S, Anderson CR.

Am J Health Syst Pharm. 2019 May 17;76(11):815-819. doi: 10.1093/ajhp/zxz055.

PMID:
31361813
5.

Influencing the timing of parenteral nutrition initiation in the pediatric intensive care unit.

Anderson CR, Lueckler J, Olson JA.

Pharm Pract (Granada). 2019 Apr-Jun;17(2):1416. doi: 10.18549/PharmPract.2019.2.1416. Epub 2019 Jun 6.

6.

Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.

Sparano JA, Gray RJ, Ravdin PM, Makower DF, Pritchard KI, Albain KS, Hayes DF, Geyer CE Jr, Dees EC, Goetz MP, Olson JA Jr, Lively T, Badve SS, Saphner TJ, Wagner LI, Whelan TJ, Ellis MJ, Paik S, Wood WC, Keane MM, Gomez Moreno HL, Reddy PS, Goggins TF, Mayer IA, Brufsky AM, Toppmeyer DL, Kaklamani VG, Berenberg JL, Abrams J, Sledge GW Jr.

N Engl J Med. 2019 Jun 20;380(25):2395-2405. doi: 10.1056/NEJMoa1904819. Epub 2019 Jun 3.

PMID:
31157962
7.

Parathyroid-Targeted Overexpression of Regulator of G-Protein Signaling 5 (RGS5) Causes Hyperparathyroidism in Transgenic Mice.

Balenga N, Koh J, Azimzadeh P, Hogue J, Gabr M, Stains JP, Olson JA Jr.

J Bone Miner Res. 2019 May;34(5):955-963. doi: 10.1002/jbmr.3674. Epub 2019 Feb 28.

PMID:
30690792
8.

Single-center experience of the FIRM technique to ablate paroxysmal and persistent atrial fibrillation.

Henley P, Foreman JR, Padanilam BJ, Nair GV, Olson JA, Joshi S, Aziz Z, Foster T, Prystowsky EN.

J Cardiovasc Electrophysiol. 2019 Apr;30(4):493-502. doi: 10.1111/jce.13832. Epub 2019 Jan 8.

PMID:
30580474
9.

EEG-Neurofeedback and the Correction of Misleading Information: A Reply to Pigott and Colleagues.

Thibault RT, Veissière S, Olson JA, Raz A.

J Atten Disord. 2018 Oct 31:1087054718808379. doi: 10.1177/1087054718808379. [Epub ahead of print] No abstract available.

PMID:
30378452
10.

Ask the pendulum: personality predictors of ideomotor performance.

Olson JA, Jeyanesan E, Raz A.

Neurosci Conscious. 2017 Aug 2;2017(1):nix014. doi: 10.1093/nc/nix014. eCollection 2017.

11.

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.

Sparano JA, Gray RJ, Makower DF, Pritchard KI, Albain KS, Hayes DF, Geyer CE Jr, Dees EC, Goetz MP, Olson JA Jr, Lively T, Badve SS, Saphner TJ, Wagner LI, Whelan TJ, Ellis MJ, Paik S, Wood WC, Ravdin PM, Keane MM, Gomez Moreno HL, Reddy PS, Goggins TF, Mayer IA, Brufsky AM, Toppmeyer DL, Kaklamani VG, Berenberg JL, Abrams J, Sledge GW Jr.

N Engl J Med. 2018 Jul 12;379(2):111-121. doi: 10.1056/NEJMoa1804710. Epub 2018 Jun 3.

12.

Pediatric lateral neck infections - Computed tomography vs ultrasound on initial evaluation.

Quinn NA, Olson JA, Meier JD, Baskin H, Schunk JE, Thorell EA, Hodo LN.

Int J Pediatr Otorhinolaryngol. 2018 Jun;109:149-153. doi: 10.1016/j.ijporl.2018.04.001. Epub 2018 Apr 7.

PMID:
29728170
13.

Treating ADHD With Suggestion: Neurofeedback and Placebo Therapeutics.

Thibault RT, Veissière S, Olson JA, Raz A.

J Atten Disord. 2018 Jun;22(8):707-711. doi: 10.1177/1087054718770012. Epub 2018 May 2.

14.

New insight into the action of tryptanthrins against Plasmodium falciparum: Pharmacophore identification via a novel submolecular QSAR descriptor.

Olson JA, Terryn RJ 3rd, Stewart EL, Baum JC, Novak MJ.

J Mol Graph Model. 2018 Mar;80:138-146. doi: 10.1016/j.jmgm.2017.12.013. Epub 2017 Dec 27.

PMID:
29346080
15.

Polyclonal origin of parathyroid tumors is common and is associated with multiple gland disease in primary hyperparathyroidism.

Shi Y, Azimzadeh P, Jamingal S, Wentworth S, Ferlitch J, Koh J, Balenga N, Olson JA Jr.

Surgery. 2018 Jan;163(1):9-14. doi: 10.1016/j.surg.2017.04.038.

16.

Association Between Vancomycin Trough Concentrations and Duration of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children.

Hsu AJ, Hamdy RF, Huang Y, Olson JA, Ghobrial S, Gerber JS, Hersh AL, Tamma PD.

J Pediatric Infect Dis Soc. 2018 Dec 3;7(4):338-341. doi: 10.1093/jpids/pix068.

PMID:
28992126
17.

Reporter gene assays for investigating GPCR signaling.

Azimzadeh P, Olson JA Jr, Balenga N.

Methods Cell Biol. 2017;142:89-99. doi: 10.1016/bs.mcb.2017.07.006. Epub 2017 Sep 1.

PMID:
28964343
18.

Cytoplasmic Cyclin E Mediates Resistance to Aromatase Inhibitors in Breast Cancer.

Doostan I, Karakas C, Kohansal M, Low KH, Ellis MJ, Olson JA Jr, Suman VJ, Hunt KK, Moulder SL, Keyomarsi K.

Clin Cancer Res. 2017 Dec 1;23(23):7288-7300. doi: 10.1158/1078-0432.CCR-17-1544. Epub 2017 Sep 25.

19.

Loss of MutL Disrupts CHK2-Dependent Cell-Cycle Control through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer.

Haricharan S, Punturi N, Singh P, Holloway KR, Anurag M, Schmelz J, Schmidt C, Lei JT, Suman V, Hunt K, Olson JA Jr, Hoog J, Li S, Huang S, Edwards DP, Kavuri SM, Bainbridge MN, Ma CX, Ellis MJ.

Cancer Discov. 2017 Oct;7(10):1168-1183. doi: 10.1158/2159-8290.CD-16-1179. Epub 2017 Aug 11.

20.

Pupil dilation to illusory motion in peripheral drift images: Perception versus reality.

Beukema S, Olson JA, Jennings BJ, Kingdom FAA.

J Vis. 2017 Jul 1;17(8):1. doi: 10.1167/17.8.1.

PMID:
28672367
21.

Epidemiology of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children.

Hamdy RF, Hsu AJ, Stockmann C, Olson JA, Bryan M, Hersh AL, Tamma PD, Gerber JS.

Pediatrics. 2017 Jun;139(6). pii: e20170183. doi: 10.1542/peds.2017-0183. Epub 2017 May 5.

22.

Tissue pharmacokinetics and pharmacodynamics of AmBisome® (L-AmBis) in uninfected and infected animals and their effects on dosing regimens.

Adler-Moore JP, Proffitt RT, Olson JA, Jensen GM.

J Liposome Res. 2017 Sep;27(3):195-209. doi: 10.1080/08982104.2017.1327543. Epub 2017 May 31. Review.

PMID:
28480760
23.

On Suggestibility and Placebo: A Follow-Up Study.

Lifshitz M, Sheiner EO, Olson JA, Thériault R, Raz A.

Am J Clin Hypn. 2017 Apr;59(4):385-392. doi: 10.1080/00029157.2016.1225252.

PMID:
28300519
24.

Identification of a 10/10 matched donor for patients with an uncommon haplotype is unlikely.

Olson JA, Gibbens Y, Tram K, Kempenich J, Novakovich J, Buck K, Dehn J.

HLA. 2017 Feb;89(2):77-81. doi: 10.1111/tan.12946.

PMID:
28102042
25.

Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance).

Ellis MJ, Suman VJ, Hoog J, Goncalves R, Sanati S, Creighton CJ, DeSchryver K, Crouch E, Brink A, Watson M, Luo J, Tao Y, Barnes M, Dowsett M, Budd GT, Winer E, Silverman P, Esserman L, Carey L, Ma CX, Unzeitig G, Pluard T, Whitworth P, Babiera G, Guenther JM, Dayao Z, Ota D, Leitch M, Olson JA Jr, Allred DC, Hunt K.

J Clin Oncol. 2017 Apr 1;35(10):1061-1069. doi: 10.1200/JCO.2016.69.4406. Epub 2017 Jan 3.

26.

A Retrospective Study of the Impact of Rapid Diagnostic Testing on Time to Pathogen Identification and Antibiotic Use for Children with Positive Blood Cultures.

Veesenmeyer AF, Olson JA, Hersh AL, Stockmann C, Korgenski K, Thorell EA, Pavia AT, Blaschke AJ.

Infect Dis Ther. 2016 Dec;5(4):555-570. Epub 2016 Nov 10.

27.

Orphan Adhesion GPCR GPR64/ADGRG2 Is Overexpressed in Parathyroid Tumors and Attenuates Calcium-Sensing Receptor-Mediated Signaling.

Balenga N, Azimzadeh P, Hogue JA, Staats PN, Shi Y, Koh J, Dressman H, Olson JA Jr.

J Bone Miner Res. 2017 Mar;32(3):654-666. doi: 10.1002/jbmr.3023. Epub 2016 Nov 25.

28.

Editorial: The Psychology of Magic and the Magic of Psychology.

Kuhn G, Olson JA, Raz A.

Front Psychol. 2016 Sep 16;7:1358. eCollection 2016. No abstract available.

29.

Simulated thought insertion: Influencing the sense of agency using deception and magic.

Olson JA, Landry M, Appourchaux K, Raz A.

Conscious Cogn. 2016 Jul;43:11-26. doi: 10.1016/j.concog.2016.04.010. Epub 2016 May 18.

PMID:
27208648
30.

Modelling the cost-effectiveness of adopting risk-stratified approaches to extended screening intervals in the national diabetic retinopathy screening programme in Scotland.

Scotland G, McKeigue P, Philip S, Leese GP, Olson JA, Looker HC, Colhoun HM, Javanbakht M.

Diabet Med. 2016 Jul;33(7):886-95. doi: 10.1111/dme.13129. Epub 2016 May 11.

PMID:
27040994
31.

Infectious Etiologies and Patient Outcomes in Pediatric Septic Shock.

Ames SG, Workman JK, Olson JA, Korgenski EK, Masotti S, Knackstedt ED, Bratton SL, Larsen GY.

J Pediatric Infect Dis Soc. 2017 Mar 1;6(1):80-86. doi: 10.1093/jpids/piv108.

PMID:
26837956
32.

Single-cell functional analysis of parathyroid adenomas reveals distinct classes of calcium sensing behaviour in primary hyperparathyroidism.

Koh J, Hogue JA, Wang Y, DiSalvo M, Allbritton NL, Shi Y, Olson JA Jr, Sosa JA.

J Cell Mol Med. 2016 Feb;20(2):351-9. doi: 10.1111/jcmm.12732. Epub 2015 Dec 5.

33.

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.

Sparano JA, Gray RJ, Makower DF, Pritchard KI, Albain KS, Hayes DF, Geyer CE Jr, Dees EC, Perez EA, Olson JA Jr, Zujewski J, Lively T, Badve SS, Saphner TJ, Wagner LI, Whelan TJ, Ellis MJ, Paik S, Wood WC, Ravdin P, Keane MM, Gomez Moreno HL, Reddy PS, Goggins TF, Mayer IA, Brufsky AM, Toppmeyer DL, Kaklamani VG, Atkins JN, Berenberg JL, Sledge GW.

N Engl J Med. 2015 Nov 19;373(21):2005-14. doi: 10.1056/NEJMoa1510764. Epub 2015 Sep 27.

34.

Application of human haploid cell genetic screening model in identifying the genes required for resistance to environmental toxicants: Chlorpyrifos as a case study.

Zhu J, Dubois A, Ge Y, Olson JA, Ren X.

J Pharmacol Toxicol Methods. 2015 Nov-Dec;76:76-82. doi: 10.1016/j.vascn.2015.08.154. Epub 2015 Aug 20.

35.

Use of computer decision support in an antimicrobial stewardship program (ASP).

Evans RS, Olson JA, Stenehjem E, Buckel WR, Thorell EA, Howe S, Wu X, Jones PS, Lloyd JF.

Appl Clin Inform. 2015 Mar 3;6(1):120-35. doi: 10.4338/ACI-2014-11-RA-0102. eCollection 2015.

36.

Explanations of a magic trick across the life span.

Olson JA, Demacheva I, Raz A.

Front Psychol. 2015 Mar 6;6:219. doi: 10.3389/fpsyg.2015.00219. eCollection 2015.

37.

Influencing choice without awareness.

Olson JA, Amlani AA, Raz A, Rensink RA.

Conscious Cogn. 2015 Dec;37:225-36. doi: 10.1016/j.concog.2015.01.004. Epub 2015 Feb 7.

PMID:
25666736
38.

Correlation of weight-based i.v. immune globulin doses with changes in serum immunoglobulin G levels.

Anderson CR, Olson JA.

Am J Health Syst Pharm. 2015 Feb 15;72(4):285-9. doi: 10.2146/ajhp140171.

PMID:
25631835
39.

Toxicity and efficacy differences between liposomal amphotericin B formulations in uninfected and Aspergillus fumigatus infected mice.

Olson JA, Schwartz JA, Hahka D, Nguyen N, Bunch T, Jensen GM, Adler-Moore JP.

Med Mycol. 2015 Feb 1;53(2):107-18. doi: 10.1093/mmy/myu070. Epub 2014 Dec 30.

PMID:
25550388
40.

Quality assurance in diabetic retinal screening in South Africa.

Cook S, Staff RT, Goatman KA, Olson JA; Scottish Diabetic Retinopathy Screening collaborative.

S Afr Med J. 2014 Sep 3;104(10):700-4. doi: 10.7196/samj.8678.

PMID:
25363058
41.

Response to Dr Clearkin.

Williams G, Olson JA.

Eye (Lond). 2014 Dec;28(12):1523. doi: 10.1038/eye.2014.205. Epub 2014 Sep 5. No abstract available.

42.

Respiratory failure during infusion of pamidronate in a 3 year-old male with osteogenesis imperfecta: a case report.

Olson JA.

J Pediatr Rehabil Med. 2014;7(2):155-8. doi: 10.3233/PRM-140284.

PMID:
25096867
43.

Electrocardiographic features and prevalence of bilateral bundle-branch delay.

Tzogias L, Steinberg LA, Williams AJ, Morris KE, Mahlow WJ, Fogel RI, Olson JA, Prystowsky EN, Padanilam BJ.

Circ Arrhythm Electrophysiol. 2014 Aug;7(4):640-4. doi: 10.1161/CIRCEP.113.000999. Epub 2014 Jul 11.

PMID:
25015953
44.

Herpes zoster ophthalmicus reduction: implementation of shingles vaccination in the UK.

Potts A, Williams GJ, Olson JA, Pollock KG, Murdoch H, Cameron JC.

Eye (Lond). 2014 Mar;28(3):247-8. doi: 10.1038/eye.2013.303. No abstract available.

45.

Rates of referable eye disease in the Scottish National Diabetic Retinopathy Screening Programme.

Looker HC, Nyangoma SO, Cromie DT, Olson JA, Leese GP, Black MW, Doig J, Lee N, Lindsay RS, McKnight JA, Morris AD, Pearson DW, Philip S, Wild SH, Colhoun HM; Scottish Diabetes Research Network Epidemiology Group; Scottish Diabetic Retinopathy Collaborative.

Br J Ophthalmol. 2014 Jun;98(6):790-5. doi: 10.1136/bjophthalmol-2013-303948. Epub 2014 Mar 5.

46.

Functional and genetic studies of isolated cells from parathyroid tumors reveal the complex pathogenesis of parathyroid neoplasia.

Shi Y, Hogue J, Dixit D, Koh J, Olson JA Jr.

Proc Natl Acad Sci U S A. 2014 Feb 25;111(8):3092-7. doi: 10.1073/pnas.1319742111. Epub 2014 Feb 7.

47.

Patterns of health care utilization among vulnerable populations in Central Texas using data from a regional health information exchange.

Schiefelbein EL, Olson JA, Moxham JD.

J Health Care Poor Underserved. 2014 Feb;25(1):37-51. doi: 10.1353/hpu.2014.0020.

PMID:
24509011
48.

Risk stratification for diabetic eye screening. Reply to Stratton I. M. and Aldington S. J. [letter].

Looker HC, Nyangoma SO, Cromie DT, Olson JA, Leese GP, Philip S, Black MW, Doig J, Lee N, Briggs A, Hothersall EJ, Morris AD, Lindsay RS, McKnight JA, Pearson DW, Sattar NA, Wild SH, McKeigue P, Colhoun HM; Scottish Diabetes Research Network Epidemiology Group and the Scottish Diabetic Retinopathy Collaborative.

Diabetologia. 2014 Jan;57(1):260-1. doi: 10.1007/s00125-013-3099-2. Epub 2013 Nov 8. No abstract available.

PMID:
24201576
49.

Effector-like CD8⁺ T cells in the memory population mediate potent protective immunity.

Olson JA, McDonald-Hyman C, Jameson SC, Hamilton SE.

Immunity. 2013 Jun 27;38(6):1250-60. doi: 10.1016/j.immuni.2013.05.009. Epub 2013 Jun 6.

50.

Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme.

Looker HC, Nyangoma SO, Cromie DT, Olson JA, Leese GP, Philip S, Black MW, Doig J, Lee N, Briggs A, Hothersall EJ, Morris AD, Lindsay RS, McKnight JA, Pearson DW, Sattar NA, Wild SH, McKeigue P, Colhoun HM; Scottish Diabetes Research Network (SDRN) Epidemiology Group and the Scottish Diabetic Retinopathy Collaborative.

Diabetologia. 2013 Aug;56(8):1716-25. doi: 10.1007/s00125-013-2928-7. Epub 2013 May 21.

Supplemental Content

Loading ...
Support Center